Provided by Tiger Trade Technology Pte. Ltd.

Biogen

222.08
+3.961.82%
Volume:243.59K
Turnover:53.81M
Market Cap:32.79B
PE:39.45
High:222.85
Open:218.93
Low:218.00
Close:218.12
52wk High:222.85
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.45
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.74
PE(LYR):25.27

Loading ...

Biogen is Maintained at Outperform by RBC Capital

Dow Jones
·
Yesterday

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Yesterday

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

TIPRANKS
·
Yesterday

RBC Capital Adjusts Price Target on Biogen to $260 From $240

MT Newswires Live
·
Yesterday

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live
·
Aug 24

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

TIPRANKS
·
Aug 24

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS
·
Aug 24

How Investors Are Reacting To Biogen (BIIB) Raising EPS Guidance On Late-Stage Drug Trial Milestones

Simply Wall St.
·
Aug 23

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Biogen Expands Autoimmune Pipeline With New Graves’ Disease Trial

TIPRANKS
·
Aug 22

Biogen Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 11 of 19 Names at New Peaks

Reuters
·
Aug 20

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

TIPRANKS
·
Aug 14

Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300

MT Newswires Live
·
Aug 13

Barclays Keeps Their Hold Rating on Biogen (BIIB)

TIPRANKS
·
Aug 13

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Reuters
·
Aug 13

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Biogen’s Long-Term Spinraza Study Wraps Up, Setting the Stage for Key SMA Data

TIPRANKS
·
Aug 12